» Articles » PMID: 29447181

Innate Immune Responses Following Kawasaki Disease and Toxic Shock Syndrome

Overview
Journal PLoS One
Date 2018 Feb 16
PMID 29447181
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The pathogenesis of Kawasaki disease (KD) remains unknown and there is accumulating evidence for the importance of the innate immune system in initiating and mediating the host inflammatory response. We compared innate immune responses in KD and toxic shock syndrome (TSS) participants more than two years after their acute illness with control participants to investigate differences in their immune phenotype. Toxic shock syndrome shares many clinical features with KD; by including both disease groups we endeavoured to explore changes in innate immune responses following acute inflammatory illnesses more broadly. We measured the in vitro production of interferon (IFN)-γ, tumour necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, IL-1 receptor antagonist (IL-1ra), and IL-10 following whole blood stimulation with toll-like receptor and inflammasome ligands in 52 KD, 20 TSS, and 53 control participants in a case-control study. Analyses were adjusted for age, sex, and unstimulated cytokine concentrations. Compared to controls, KD participants have reduced IL-1ra production in response to stimulation with double stranded RNA (geometric mean ratio (GMR) 0.37, 95% CI 0.15, 0.89, p = 0.03) and increased IL-6 production in response to incubation with Lyovec™ (GMR 5.48, 95% CI 1.77, 16.98, p = 0.004). Compared to controls, TSS participants have increased IFN-γ production in response to peptidoglycan (GMR 4.07, 95% CI 1.82, 9.11, p = 0.001), increased IL-1β production to lipopolysaccharide (GMR 1.64, 95% CI 1.13, 2.38, p = 0.01) and peptidoglycan (GMR 1.61, 95% CI 1.11, 2.33, p = 0.01), and increased IL-6 production to peptidoglycan (GMR 1.45, 95% CI 1.10, 1.92, p = 0.01). Years following the acute illness, individuals with previous KD or TSS exhibit a pro-inflammatory innate immune phenotype suggesting a possible underlying immunological susceptibility or innate immune memory.

Citing Articles

Association between gene polymorphisms and coronary artery lesion in Kawasaki disease.

Liu X, Chen Y, Yang Y, Su Z, Wang F, Zhanghuang C Front Med (Lausanne). 2023; 10:1193303.

PMID: 37575991 PMC: 10413112. DOI: 10.3389/fmed.2023.1193303.


Identifying differentially expressed genes and miRNAs in Kawasaki disease by bioinformatics analysis.

Cai Y, Hu W Sci Rep. 2022; 12(1):21879.

PMID: 36536067 PMC: 9763244. DOI: 10.1038/s41598-022-26608-x.


Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral NLRP3 Inflammasome Inhibitor ZYIL1: First-in-Human Phase 1 Studies (Single Ascending Dose and Multiple Ascending Dose).

Parmar D, Kansagra K, Momin T, Patel H, Jansari G, Bhavsar J Clin Pharmacol Drug Dev. 2022; 12(2):202-211.

PMID: 36065092 PMC: 10087697. DOI: 10.1002/cpdd.1162.


Correlation Between Matrix Metalloproteinases With Coronary Artery Lesion Caused by Kawasaki Disease.

Tian F, Ma L, Zhao R, Ji L, Wang X, Sun W Front Pediatr. 2022; 10:802217.

PMID: 35223694 PMC: 8874123. DOI: 10.3389/fped.2022.802217.


Complement 3 and the Prognostic Nutritional Index Distinguish Kawasaki Disease from Other Fever Illness with a Nomogram.

Huang Y, Liu X, Xia H, Cui L, Lang X, Liu C Children (Basel). 2021; 8(9).

PMID: 34572257 PMC: 8466424. DOI: 10.3390/children8090825.


References
1.
Alphonse M, Duong T, Shumitzu C, Hoang T, McCrindle B, Franco A . Inositol-Triphosphate 3-Kinase C Mediates Inflammasome Activation and Treatment Response in Kawasaki Disease. J Immunol. 2016; 197(9):3481-3489. DOI: 10.4049/jimmunol.1600388. View

2.
. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J. 2014; 78(10):2521-62. DOI: 10.1253/circj.cj-66-0096. View

3.
Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y . Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol. 2012; 22(3):216-21. PMC: 3798622. DOI: 10.2188/jea.je20110126. View

4.
Uehara R, Belay E . Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012; 22(2):79-85. PMC: 3798585. DOI: 10.2188/jea.je20110131. View

5.
Zhang Y, Chen S, Huang G, Zhang H, Huang M, Wang S . Coronary artery indexed diameter and z score regression equations in healthy Chinese Han children. J Clin Ultrasound. 2014; 43(1):39-46. DOI: 10.1002/jcu.22176. View